Evidence map›Paper›PMID 34731264›Full record

ArticleWorld journal of urology2022

Preoperative clinical and radiographic predictors of major vascular surgery in patients with testicular cancer undergoing post-chemotherapy residual tumor resection (PC-RPLND).

Alessandro Nini, Matthias Boschheidgen, Andreas Hiester, Christian Winter, Gerald Antoch, Lars Schimmöller, Peter Albers

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Special Issue on Testis Cancer.World journal of urology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Alessandro Nini *Department of Urology and Pediatric Urology, Saarland University Medical Center, Universitätsklinikum des Saarlandes, Saarland University, 66421, Homburg/Saar, Germany. alenini87@gmail.com.ORCID http://orcid.org/0000-0002-2548-6495
Matthias Boschheidgen *Institute for Diagnostic and Interventional Radiology, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Andreas HiesterDepartment of Urology, Medical Faculty, University Hospital, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Christian WinterDepartment of Urology, Medical Faculty, University Hospital, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Gerald AntochInstitute for Diagnostic and Interventional Radiology, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Lars SchimmöllerInstitute for Diagnostic and Interventional Radiology, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Peter AlbersDepartment of Urology, Medical Faculty, University Hospital, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Düsseldorf University Hospital · DEVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the probability to correctly predict major vascular surgery (MVS) in patients undergoing postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for testicular cancer.

methodsFrom a database of 504 RPLNDs performed in 434 patients (2008-2018), 78 patients submitted to PC-RPLND for non-seminoma germ-cell cancer after cisplatin-based chemotherapy with available preoperative CT scans were identified. Second PC-PLNDs (Re-Dos), salvage RPLNDs, or RPLNDs for late-relapse were excluded as well as thoraco-abdominal approaches. Preoperative imaging was reviewed by a urologist and a radiologist blinded to operative details.

resultsOf 78 patients, 16 (20.5%) underwent MVS (caval and/or aortic replacement or reconstruction). On univariable analyses, transversal diameter, sagittal diameter, tumor volume, aorta- and cava-tumor contact angle, poor IGCCCG score, clinical stage III and preoperative positive markers were predictors of MVS (all p values ≤ 0.01). At multivariable analyses aorta- (cut-off 64°) and cava-tumor contact angle (cut-off 98°) and poor IGCCCG score represented the three most important predictors of MVS (all p values ≤ 0.05). The model constructed has a PPV 100%, NPV 87% and an accuracy of 88%.

conclusionsPresence of aorta-tumor contact angle ≥ 64°, cava-tumor contact angle ≥ 98° and poor IGCCCG score identify correctly 9 out of 10 patients requiring MVS at the time of first PC-RPLND.

Indexed as

Neoplasms, Germ Cell and EmbryonalTesticular NeoplasmsHumansLymph Node ExcisionMaleNeoplasm, ResidualRetroperitoneal SpaceRetrospective StudiesVascular Surgical ProceduresPC-RPLNDRadiologyTesticular cancerVascular surgery

Identifiers

PMID34731264
OpenAlexW3210290381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.